SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $189,362 | -73.6% | 40,723 | -73.8% | 0.00% | -100.0% |
| Q1 2023 | $717,019 | -67.8% | 155,199 | -43.7% | 0.00% | -50.0% |
| Q4 2022 | $2,226,775 | +27.4% | 275,591 | -12.5% | 0.00% | 0.0% |
| Q3 2022 | $1,748,000 | +29.4% | 315,014 | +21.4% | 0.00% | 0.0% |
| Q2 2022 | $1,351,000 | +196.3% | 259,397 | +745.9% | 0.00% | – |
| Q4 2021 | $456,000 | -35.4% | 30,664 | -18.0% | 0.00% | -100.0% |
| Q3 2021 | $706,000 | +31.0% | 37,387 | +29.0% | 0.00% | – |
| Q2 2021 | $539,000 | -44.4% | 28,977 | -32.0% | 0.00% | -100.0% |
| Q1 2021 | $970,000 | -54.7% | 42,606 | -56.8% | 0.00% | -50.0% |
| Q4 2020 | $2,141,000 | – | 98,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |